Case Study:
Customer Excellence With AI Sales Rep Tools Brings in $937 Million in Incremental Growth
AI-Powered Sales Tool Delivers 43% Growth
Pharma sales reps have an increasingly difficult time. Whether their brand is a new launch, or there are competitor brands providing intense competition, or generic competition, the sales reps need to be armed with as much information on their therapy area and customers than ever before. The reps need the best information on everything possible, including predictions about their customers’ needs and behaviors.
The Client Problem
• Large, but older, brand in decline
• New brands with new treatment paradigms
• Generic competition
• Sales representatives felt they could not compete anymore
• Sales Director wanted to see if AI could give the reps a competitive edge
The Solution
• Rich individual physician level data within the CRM system
• Online data that could be linked to specific physicians
• Combined all data available into a uniform format, plus temporal sequencing
• Used AI techniques, thereafter, to create tools that provided actionable insights
• Physician switch warning behaviors sent to sales rep
• Bespoke sales message suggestion engine for individual physicians
• Bespoke detail aids for each physician created in the doctor’s office
The Outcome
• 43% increase in sales in reps using the system compared with the reps not using the system
• Was then rolled out to integrate into CRM system
• Overall incremental sales growth was $937 Million
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
You Didn’t Have an AI Problem. You Had a Capability Problem.
There is a meeting that happens in many pharmaceutical companies about eighteen months after the AI budget is approved. The slides are polished. There is
We’re Doing AI” Is Not a Board Answer
There is a moment I have seen play out in pharmaceutical boardrooms again and again. It usually comes in the second half of the agenda,
Why Most AI Governance Frameworks Are the Wrong Fit for Pharma
Most pharmaceutical organizations now have some form of AI governance. On paper, that sounds reassuring. In practice, it often means a policy document, a review